Shareholder Alert: The Ademi Firm investigates whether Semler Scientific Inc. is obtaining a Fair Price for its Public Shareholders

Core Insights - The Ademi Firm is investigating Semler Scientific for potential breaches of fiduciary duty and other legal violations related to its transaction with Strive [1][3] - Shareholders of Semler Scientific will receive 21.05 Class A common shares of Strive, valued at approximately $90.52 per share based on trading prices as of September 19, 2025 [2] - The transaction agreement restricts competing offers for Semler Scientific by imposing significant penalties for accepting alternative bids, raising concerns about the board's fiduciary responsibilities [3]